Navigation Links
DePuy Recalled Hip Device Lawsuit Filed in East Texas

TYLER, Texas, March 18, 2011 /PRNewswire/ -- Richard Dykes filed suit today against Johnson & Johnson, Inc. and DePuy Orthopaedics, Inc. seeking compensation for injuries caused by the failure of the DePuy ASR XL Acetabular Hip Replacement System that has been recalled.  John David Hart of the Law Offices of John David Hart in Fort Worth, Texas, is the attorney representing Mr. Dykes in the suit filed in the United States District Court for the Eastern District of Texas in Tyler, Texas.

On or about December 5, 2008, Mr. Dykes underwent hip replacement surgery and received an ASR XL Acetabular system with an AML femoral stem implanted in his left hip. Since the surgical implantation of the ASR XL Acetabular System in his left hip, Mr. Dykes has suffered symptoms including, but not limited to severe pain, problems sitting and standing, elevated levels of metal ions in his blood, and possible loosening.  Due to these complications, he may require a revision surgery in the future.

"The DePuy ASR XL Acetabular Hip Replacement System has an unacceptable failure rate of more than one out of every eight," said attorney John David Hart.  "One of those who was injured by this dangerous product was Richard Dykes.  Now, he lives with pain every day and is facing the potential for revision surgery.  Medical devices like the ASR XL Acetabular Hip Replacement System must be safe and effective for the health of every patient."

DePuy Orthopaedics, Inc., a division of Johnson and Johnson, Inc., recalled its ASR XL Acetabular metal-on-metal hip replacement system on August 24, 2010. This recall came after data from a recent study indicated that the five year failure rate of this product is approximately 13%, or more than 1 out of every 8 patients. DePuy identified reasons for the failure of the hip replacement system as component loosening, component malalignment, infection, fracture of the bone, dislocation, metal sensitivity and pain. Additional complications from the DePuy ASR XL Acetabular hip replacement system may include increased metal ion levels in the blood, bone staining, necrosis, swelling, nerve damage, tissue damage and/or muscle damage. This device was marketed by DePuy Orthopaedics as a high performance hip replacement system.

John David Hart and the Law Offices of John David Hart represent many individuals in the United States who have been injured as a result of this defective hip replacement system.  The Law Offices of John David Hart is a group of experienced and dedicated legal professionals working to protect the rights of people wronged by the acts of others.  Across the country, the firm represents individuals in cases of catastrophic personal injury, wrongful death, dangerous drugs, automobile and truck accidents and oil and gas litigation. For more information, please contact John Hart at 800.961.4278 or

SOURCE The Law Offices of John David Hart
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Woman Files Suit in Beaumont, Texas Federal Court Against DePuy Orthopaedics and Johnson & Johnson Over Recalled Hip Device
2. Woman Files Suit in Federal Court Against DePuy Orthopaedics, Inc.,/Johnson & Johnson Over Recalled Hip Device
3. Rottenstein Law Group Applauds New Efforts of U.S. FDA to Look More Carefully at Metal-on-Metal Implants After DePuy Recall
4. Johnson & Johnson Recall of DePuy Hip Devices: Lewitt Hackman Files Suit
5. Burg Simpson Leads National Litigation Against DePuy Orthopaedics, Inc.
6. Chesley Files Class Action Against DePuy Orthopaedics
7. Federal Panel Grants Lanier Law Firm Motion for Hearing on National Coordination of DePuy Hip Implant Lawsuits
8. DePuy Orthopaedics Accused of Deceiving Hip Replacement Patients
9. DePuy Hip Recall & Avandia Focus of Nov. 3 Conference, HB Announces
10. Class Action Lawsuit Filed Against DePuy Orthopaedics, Inc.
11. DePuy Orthopaedics Voluntarily Recalls ASR™ Hip System
Post Your Comments:
(Date:11/26/2015)... , November 26, 2015 ... potential to use SyMRI to find optimal contrast weighting of ... tumor metastases, and has signed a research agreement with SyntheticMR ... the hospital. Using SyMRI, it is possible to generate multiple ... settings after the patient has left, thus making it possible ...
(Date:11/26/2015)... -- 3D bioprinting market is expected to ... report by Grand View Research Inc. Rising prevalence of chronic ... transplantation is expected to boost the market growth, as 3D ... --> 3D bioprinting market is expected to ... report by Grand View Research Inc. Rising prevalence of chronic ...
(Date:11/26/2015)... DUBLIN , November 26, 2015 /PRNewswire/ ... the addition of the "2016 Future ... Drugs of Abuse Testing Market: Supplier Shares, ... report to their offering. --> ... of the "2016 Future Horizons and ...
Breaking Medicine Technology:
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... On November ... training center for the Narconon network, announced the release of a new cutting edge ... the Narconon organization has been working with drug- and alcohol-addicted individuals with the purpose ...
(Date:11/25/2015)... , ... November 25, 2015 , ... On November 23rd ... Tri Lite’s personal heating products business. Cozy Products explains what this means ... that fit in well with the Cozy Products business model: to sell personal heaters ...
(Date:11/25/2015)... ALTO, Calif. (PRWEB) , ... November 25, 2015 , ... ... Smart and Beddit Classic sleep tracking systems. The new app features a more intuitive ... see and understand how well you slept. The SleepScore is created by a proprietary ...
(Date:11/25/2015)... ... November 25, 2015 , ... “While riding the bus, I saw a ... “I thought there had to be a convenient and comfortable way to protect them ... enables disabled individuals to safely travel during cold or inclement weather. In doing so, ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... (PHA) announces the nation’s Periwinkle Pioneers, individuals and groups responsible for advancing care ... disease. The Periwinkle Pioneers, nominated by the public, will receive special recognition throughout ...
Breaking Medicine News(10 mins):